Dallas, TX-A new potential risk marker—monocyte chemoattractant protein-1 (MCP-1)—has been shown to provide independent prognostic value in ACS patients and might also be a good therapeutic target, ...
Atherogenesis is a chronic inflammatory process. Critical in the inflammation process is monocyte chemoattractant protein-1 (MCP-1). To locate genomic regions that affect circulating MCP-1 levels, a ...
TIMP-1 induces Fli-1 expression through miRNA-145, subsequently increasing MCP-1 expression and macrophage recruitment. MiRNA-145-enriched EVs from HSCs can transmit biological information and magnify ...
The monocyte chemoattractant protein-1 is a potent cell signaling molecule involved in the activation of mononuclear phagocytes, but its role in the pathogenesis of HIV-associated dementia (HAD) has ...
Researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) have shown, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results